QTI vs. TLSI, INGN, SGHT, PROF, CVRX, KRMD, ELMD, PDEX, LNSR, and RCEL
Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include TriSalus Life Sciences (TLSI), Inogen (INGN), Sight Sciences (SGHT), Profound Medical (PROF), CVRx (CVRX), KORU Medical Systems (KRMD), Electromed (ELMD), Pro-Dex (PDEX), LENSAR (LNSR), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.
QT Imaging vs. Its Competitors
TriSalus Life Sciences (NASDAQ:TLSI) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.
2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 27.5% of TriSalus Life Sciences shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
TriSalus Life Sciences currently has a consensus price target of $10.75, indicating a potential upside of 133.70%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe TriSalus Life Sciences is more favorable than QT Imaging.
In the previous week, QT Imaging had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 1.89 beat QT Imaging's score of 0.73 indicating that TriSalus Life Sciences is being referred to more favorably in the media.
QT Imaging has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -84.67%.
TriSalus Life Sciences has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, meaning that its stock price is 120% less volatile than the S&P 500.
QT Imaging has lower revenue, but higher earnings than TriSalus Life Sciences.
Summary
TriSalus Life Sciences and QT Imaging tied by winning 7 of the 14 factors compared between the two stocks.
Get QT Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
QT Imaging Competitors List
Related Companies and Tools
This page (NASDAQ:QTI) was last updated on 7/18/2025 by MarketBeat.com Staff
